Gastroenterology & Hepatology

Hepatitis B and Hepatitis C

This track focuses on recent advancements in the diagnosis, treatment, and prevention of viral hepatitis, including hepatitis B and hepatitis C. Researchers evaluate the efficacy of direct-acting antiviral agents (DAAs), novel therapeutic combinations, and immunomodulatory approaches for achieving sustained virologic response (SVR) and reducing the burden of liver-related morbidity and mortality associated with chronic hepatitis B and C infections.